The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans in health. Areas of focus for GlycoNet in Cycle II (2020–2024) are cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.
GlycoNet funds projects along the following research innovation continuum: translational research and development, clinical engagement, technology development, and knowledge and technology exchange and exploitation (KTEE).
These grants offer funding opportunities for clinicians to validate glycomics data from clinical studies. Maximum request: $50,000 for one year.
These grants further advance/translate projects with proof of concept and protected IP. Maximum request: $150,000 for one year, 1:1 matching required.
These grants fund partner-led initiatives to advance a partner challenge. Maximum request: $150,000 for one year, with possibility of one year renewal, 1:1 matching required.
GlycoNet has formalized a partnership with Academia Sinica to co-fund collaborative research between two entities. These grants fund projects that involve at least two groups, one in Canada and one in Taiwan. GlycoNet will fund research conducted in Canada, while Academia Sinica will fund research conducted in Taiwan. Projects require at least a 1:1 matching and must be completed within 12 months.
Applications are accepted and reviewed on a rolling basis.
The next application deadline for Clinical Partnerships, Translational Grants, and Strategic Initiatives is July 15, 2022.